UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 85

Sortiert nach

Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study

Clinical infectious diseases, 2022-04, Vol.74 (7), p.1191-1198

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical characterization and possible pathophysiological causes of the Deventilation Syndrome in COPD

Scientific reports, 2022-01, Vol.12 (1), p.1099-1099, Article 1099

2022

Link zum Volltext

Verfügbarkeit prüfen

Detrended fluctuation analysis and adaptive fractal analysis of stride time data in Parkinson's disease: stitching together short gait trials

PloS one, 2014-01, Vol.9 (1), p.e85787-e85787

2014

Link zum Volltext

Verfügbarkeit prüfen

Optimal designs for phase II/III drug development programs including methods for discounting of phase II results

BMC medical research methodology, 2020-10, Vol.20 (1), p.253-253, Article 253

2020

Link zum Volltext

Verfügbarkeit prüfen

Gene Polymorphisms of NOD2, IL23R, PTPN2 and ATG16L1 in Patients with Crohn’s Disease: On the Way to Personalized Medicine?

Genes, 2021-06, Vol.12 (6), p.866

2021

Link zum Volltext

Verfügbarkeit prüfen

"What would you like to achieve?" Goal-Setting in Patients with Dementia in Geriatric Rehabilitation

BMC geriatrics, 2019-10, Vol.19 (1), p.280-280, Article 280

2019

Link zum Volltext

Verfügbarkeit prüfen

Rotational thrombelastometry (ROTEM) improves hemostasis assessment compared to conventional coagulation test in ACLF and Non-ACLF patients

BMC gastroenterology, 2020-08, Vol.20 (1), p.271-271, Article 271

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of supervised immersive virtual reality-based training for the treatment of chronic fatigue in post-COVID syndrome: study protocol for a double-blind randomized controlled trial (IFATICO Trial)

Trials, 2024-04, Vol.25 (1), p.232-232

2024

Link zum Volltext

Verfügbarkeit prüfen

Utility-based optimization of phase II/III programs

Statistics in medicine, 2016-01, Vol.35 (2), p.305-316

2016

Link zum Volltext

Verfügbarkeit prüfen

Characterization of Postural Sway in Women with Osteoporosis and a Control Group by Means of Linear and Nonlinear Methods

Bioengineering (Basel), 2023-03, Vol.10 (4), p.403

2023

Link zum Volltext

Verfügbarkeit prüfen

Ellipse area calculations and their applicability in posturography

Gait & posture, 2014-01, Vol.39 (1), p.518-522

2014

Link zum Volltext

Verfügbarkeit prüfen

Plasma Lipidome, PNPLA3 polymorphism and hepatic steatosis in hereditary hemochromatosis

BMC gastroenterology, 2020-07, Vol.20 (1), p.230-9, Article 230

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient ® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)

Cancers, 2021-03, Vol.13 (6), p.1223

2021

Link zum Volltext

Verfügbarkeit prüfen

Aspirin use and bleeding events during thrombocytopenia after autologous stem-cell transplantation for multiple myeloma

Frontiers in oncology, 2023-04, Vol.13, p.1168120-1168120

2023

Link zum Volltext

Verfügbarkeit prüfen

ROBOCOP II (ROBOtic assisted versus conventional open partial nephrectomy) randomised, controlled feasibility trial: clinical trial protocol

BMJ open, 2021-11, Vol.11 (11), p.e052087-e052087

2021

Link zum Volltext

Verfügbarkeit prüfen

Sample size planning for phase II trials based on success probabilities for phase III

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2015-11, Vol.14 (6), p.515-524

2015

Link zum Volltext

Verfügbarkeit prüfen

The value of PSA density in combination with PI-RADS for the accuracy of prostate cancer prediction

The Journal of urology, 2017-09, Vol.198 (3), p.575-582

2017

Link zum Volltext

Verfügbarkeit prüfen

Auswertung Klinischer Studien Mit SPSS: Ein Leitfaden Zur Strukturierten Herangehensweise

1. Aufl. 2019 edition., 2018

Link zum Volltext

Verfügbarkeit prüfen

A Comparison of Additional Benefit Assessment Methods for Time-to-Event Endpoints Using Hazard Ratio Point Estimates or Confidence Interval Limits by Means of a Simulation Study

Medical decision making, 2024-05, Vol.44 (4), p.365-379

2024

Link zum Volltext

Verfügbarkeit prüfen

Optimal sample size allocation for two-arm superiority and non-inferiority trials with binary endpoints

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

Optimal sample size allocation and go/no‐go decision rules for phase II/III programs where several phase III trials are performed

Biometrical journal, 2019-03, Vol.61 (2), p.357-378

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Englisch
(67)
Deutsch
(19)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study

Clinical characterization and possible pathophysiological causes of the Deventilation Syndrome in COPD

Detrended fluctuation analysis and adaptive fractal analysis of stride time data in Parkinson's disease: stitching together short gait trials

Optimal designs for phase II/III drug development programs including methods for discounting of phase II results

Gene Polymorphisms of NOD2, IL23R, PTPN2 and ATG16L1 in Patients with Crohn’s Disease: On the Way to Personalized Medicine?

"What would you like to achieve?" Goal-Setting in Patients with Dementia in Geriatric Rehabilitation

Rotational thrombelastometry (ROTEM) improves hemostasis assessment compared to conventional coagulation test in ACLF and Non-ACLF patients

Efficacy of supervised immersive virtual reality-based training for the treatment of chronic fatigue in post-COVID syndrome: study protocol for a double-blind randomized controlled trial (IFATICO Trial)

Utility-based optimization of phase II/III programs

Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children

Characterization of Postural Sway in Women with Osteoporosis and a Control Group by Means of Linear and Nonlinear Methods

Ellipse area calculations and their applicability in posturography

Plasma Lipidome, PNPLA3 polymorphism and hepatic steatosis in hereditary hemochromatosis

Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient ® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)

Aspirin use and bleeding events during thrombocytopenia after autologous stem-cell transplantation for multiple myeloma

ROBOCOP II (ROBOtic assisted versus conventional open partial nephrectomy) randomised, controlled feasibility trial: clinical trial protocol

Protocol of the IntenSify‐Trial: An open‐label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab‐paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy

Determinants of Statural Growth in European Children With Chronic Kidney Disease: Findings From the Cardiovascular Comorbidity in Children With Chronic Kidney Disease (4C) Study

Sample size planning for phase II trials based on success probabilities for phase III

CDH12 as a Candidate Gene for Kidney Injury in Posterior Urethral Valve Cases: A Genome-wide Association Study Among Patients with Obstructive Uropathies

The value of PSA density in combination with PI-RADS for the accuracy of prostate cancer prediction

Auswertung Klinischer Studien Mit SPSS: Ein Leitfaden Zur Strukturierten Herangehensweise

A Comparison of Additional Benefit Assessment Methods for Time-to-Event Endpoints Using Hazard Ratio Point Estimates or Confidence Interval Limits by Means of a Simulation Study

Optimal sample size allocation for two-arm superiority and non-inferiority trials with binary endpoints

Optimal sample size allocation and go/no‐go decision rules for phase II/III programs where several phase III trials are performed

Suchergebnisse filtern